AC
ARCT icon

AXQ Capital’s Arcturus Therapeutics ARCT Stock Holding History

AXQ Capital’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$123K Sell
18,277
-4,705
-20% -$37.1K 0.01% 795
2026
Q1 		$177K Sell
22,982
-5,686
-20% -$41.5K 0.02% 777
2025
Q4 		$176K Buy
+28,668
New +$310K 0.04% 594

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

AXQ Capital's ARCT Position: Q2 2026 in Review

AXQ Capital reduced its Arcturus Therapeutics (ARCT) stake by 20% in Q2 2026, selling an estimated $37.1K and leaving 18,277 shares worth $123K. The position accounts for 0.01% of the portfolio, ranked #795.

AXQ Capital first reported a position in ARCT in Q4 2025 and has held it in 3 quarters since. The position peaked at $177K in Q1 2026. 136 funds tracked by Wall St. Rank hold ARCT as of Q2 2026.

  • AXQ Capital held 18,277 shares of Arcturus Therapeutics worth $123K as of Q2 2026.
  • AXQ Capital sold 4,705 Arcturus Therapeutics shares in Q2 2026, an estimated $37.1K.
  • Arcturus Therapeutics made up 0.01% of AXQ Capital's portfolio in Q2 2026, its #795 holding.
  • AXQ Capital first reported a position in Arcturus Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • AXQ Capital's Arcturus Therapeutics position peaked at $177K in Q1 2026.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.